{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:05:22Z","timestamp":1767704722875},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ygyno.2015.01.534","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:52:32Z","timestamp":1421801552000},"page":"571-581","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities \u2014 A systematic review"],"prefix":"10.1016","volume":"136","author":[{"given":"Rie D.","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine H.","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona A.","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus K.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.01.534_bb0005","series-title":"\u00c5rsrapport \u2013 Dansk Gyn\u00e6kologisk Cancer Database Landsd\u00e6kkende klinisk database for kr\u00e6ft i \u00e6ggestokke, livmoder og livmoderhals","author":"H\u00f8gdall LT","year":"2012"},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ygyno.2015.01.534_bb0015","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0020-7292(12)60025-3","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"119","author":"Berek","year":"2012","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"7","key":"10.1016\/j.ygyno.2015.01.534_bb0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"122","author":"Jordan","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2013.03.004","article-title":"Tu-be or not tu-be: that is the question\u2026 about serous ovarian carcinogenesis","volume":"88","author":"Chene","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.01.534_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case\u2013control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygyno.2014.08.020","article-title":"Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology\u2014a prospective comparative study","volume":"135","author":"Schnack","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0029-7844(97)00650-9","article-title":"Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer","volume":"91","author":"Eltabbakh","year":"1998","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2015.01.534_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10552-010-9525-6","article-title":"Primary peritoneal and ovarian cancers: an epidemiological comparative analysis","volume":"21","author":"Grant","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.ygyno.2015.01.534_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1525-1438.2001.01027.x","article-title":"Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer","volume":"11","author":"Halperin","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2015.01.534_bb0055","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ajog.2003.09.073","article-title":"Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study","volume":"190","author":"Barda","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1438.2006.00590.x","article-title":"Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?","volume":"16","author":"Ayhan","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2015.01.534_bb0065","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/ijc.22491","article-title":"Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975\u22122004","volume":"120","author":"Riska","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2015.01.534_bb0070","first-page":"691","article-title":"Primary carcinoma of the fallopian tube and epithelial ovarian carcinoma: a case\u2013control analysis","volume":"53","author":"Dunn","year":"2008","journal-title":"J. Reprod. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2010.03.009","article-title":"Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","article-title":"Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma\u2014a Gynecologic Oncology Group Study","volume":"89","author":"Bloss","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.534_bb0085","article-title":"Survival differences of serous tubal, ovarian, peritoneal and uterine carcinomas","author":"Usach","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2015.01.534_bb0090","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0748-7983(04)00233-1","article-title":"Prognosis of stage III or IV primary peritoneal serous papillary carcinoma","volume":"30","author":"Dubernard","year":"2004","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00004347-200404000-00011","article-title":"Expression of Cox-2, CD34, Bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma","volume":"23","author":"Khalifeh","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"12","key":"10.1016\/j.ygyno.2015.01.534_bb0100","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/cncr.23957","article-title":"Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer","volume":"113","author":"Wethington","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.01.534_bb0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2007.09.027","article-title":"Serous fallopian tube carcinoma: a retrospective, multi-institutional case\u2013control comparison to serous adenocarcinoma of the ovary","volume":"107","author":"Moore","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.2001.6176","article-title":"Allelotype of papillary serous peritoneal carcinomas","volume":"82","author":"Cass","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5","article-title":"Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases","volume":"64","author":"Dalrymple","year":"1989","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.1993.1267","article-title":"Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma","volume":"51","author":"Killackey","year":"1993","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.01.534_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.1999.5711","article-title":"Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum","volume":"76","author":"Schorge","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0130","doi-asserted-by":"crossref","first-page":"213.e1","DOI":"10.1016\/j.ajog.2007.07.003","article-title":"Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma","volume":"198","author":"Eisenhauer","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2015.01.534_bb0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1587::AID-CNCR22>3.0.CO;2-T","article-title":"A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma","volume":"79","author":"Kowalski","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2015.01.534_bb0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004347-200110000-00005","article-title":"Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma","volume":"20","author":"Halperin","year":"2001","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.01.534_bb0145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1525-1438.2003.13605.x","article-title":"Molecular similarities between primary peritoneal and primary ovarian carcinomas","volume":"13","author":"Chen","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/P51M-B66M-JFKW-ER5A","article-title":"Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum","volume":"114","author":"Huang","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.01.534_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0046-8177(00)80252-X","article-title":"Identification of a novel 9cM deletion unit on chromosome 6q23\u201324 in papillary serous carcinoma of the peritoneum","volume":"31","author":"Huang","year":"2000","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/gyno.2000.5747","article-title":"ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum","volume":"77","author":"Garrett","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S1807-59322011000100013","article-title":"Fallopian tube origin of supposed ovarian high-grade serous carcinomas","volume":"66","author":"Diniz","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.ygyno.2015.01.534_bb0175","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.01.534_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case\u2013control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.01.534_bb0190","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.ygyno.2015.01.534_bb0195","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V","article-title":"Carcinoma of the fallopian tube","volume":"89","author":"Baekelandt","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/gyno.2001.6134","article-title":"Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study","volume":"81","author":"Gadducci","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anndiagpath.2012.10.001","article-title":"Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors","volume":"17","author":"Alvarado-Cabrero","year":"2013","journal-title":"Ann. Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10147-010-0128-8","article-title":"Primary fallopian tube carcinoma: a clinicopathological analysis of a rare entity","volume":"16","author":"Koo","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-1438.2006.00292.x","article-title":"A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers","volume":"16","author":"Benoit","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7716","key":"10.1016\/j.ygyno.2015.01.534_bb0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014A Factor in Ovarian Neoplasia?","volume":"298","author":"Fathalla","year":"1971","journal-title":"The Lancet."},{"issue":"23","key":"10.1016\/j.ygyno.2015.01.534_bb0225","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.23509","article-title":"Body size and risk of epithelial ovarian and related cancers: a population-based case\u2013control study","volume":"123","author":"Olsen","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2015.01.534_bb0235","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/IGC.0b013e31826a3559","article-title":"Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study","volume":"22","author":"Luyckx","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.01.534_bb0240","first-page":"1051","article-title":"Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the \u2018MALOVA\u2019 ovarian cancer study","volume":"18","author":"Hogdall","year":"2007","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/IGC.0b013e3182788466","article-title":"Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis","volume":"23","author":"Zhao","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cncr.11476","article-title":"Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study","volume":"98","author":"Hogdall","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2015.01.534_bb0255","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/apm.12071","article-title":"Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the \u2018MALOVA\u2019 ovarian cancer study","volume":"121","author":"Heeran","year":"2013","journal-title":"Acta Pathol. Microbiol. Immunol. Scand."},{"issue":"12","key":"10.1016\/j.ygyno.2015.01.534_bb0260","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19950615)75:12<2891::AID-CNCR2820751216>3.0.CO;2-B","article-title":"c-erbB-2 and p53 expression in fallopian tube carcinoma","volume":"75","author":"Lacy","year":"1995","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.01.534_bb0265","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2559.2007.02850.x","article-title":"HER-2\/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study","volume":"51","author":"Nowee","year":"2007","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ygyno.2015.01.534_bb0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000227496","article-title":"HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube Carcinoma","volume":"52","author":"Stuhlinger","year":"1995","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.ygyno.2015.01.534_bb0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00004347-199704000-00012","article-title":"Role of p53 alteration in primary peritoneal carcinoma","volume":"16","author":"Moll","year":"1997","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"18","key":"10.1016\/j.ygyno.2015.01.534_bb0280","first-page":"5119","article-title":"Unifocal origin of advanced human epithelial ovarian cancers","volume":"52","author":"Mok","year":"1992","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.534_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/gyno.1993.1002","article-title":"Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas","volume":"48","author":"Tsao","year":"1993","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.01.534_bb0290","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.ajog.2013.08.004","article-title":"Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer","volume":"209","author":"Marchion","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2015.01.534_bb0295","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/ijc.24148","article-title":"The clonal evolution of metastases from primary serous epithelial ovarian cancers","volume":"124","author":"Khalique","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"25","key":"10.1016\/j.ygyno.2015.01.534_bb0300","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.01.534_bb0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PGP.0b013e31826a629b","article-title":"Serous tubal in situ carcinoma (STIC) in primary peritoneal serous carcinomas","volume":"32","author":"Horn","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.01.534_bb0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2015.01.534_bb0315","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.humpath.2012.12.007","article-title":"Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?","volume":"44","author":"Gao","year":"2013","journal-title":"Hum. Pathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815005387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815005387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:51:46Z","timestamp":1537941106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815005387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0090825815005387"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.534","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serous ovarian, fallopian tube and primary peritoneal cancers: A common disease or separate entities \u2014 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}